Filing Flows › Emmaus Life Sciences (EMMA) › R&D spending
Emmaus Life Sciences (EMMA) R&D spending by quarter
Emmaus Life Sciences' R&D spending was $116K in Q2 2026 (second quarter 2026), +190% from Q1 2026. Over the last 7 quarters it ranged from $31K (Q4 2025) to $176K (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $116K | +190% | +107% |
| Q1 2026 | $40K | +29% | -77% |
| Q4 2025 | $31K | -38% | -77% |
| Q3 2025 | $50K | -11% | — |
| Q2 2025 | $56K | -68% | — |
| Q1 2025 | $176K | +28% | — |
| Q4 2024 | $137K | — | — |
Q2 2026 at a glance
Emmaus Life Sciences, Q2 2026: revenue $6.3M (+124% year over year), operating margin 60.0%, net earnings $1.3M, operating cash flow $1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Emmaus Life Sciences' R&D spending?
Emmaus Life Sciences' R&D spending was $116K in Q2 2026 (second quarter 2026), +190% from Q1 2026.
How has Emmaus Life Sciences' R&D spending changed?
Over the last 7 quarters it ranged from $31K (Q4 2025) to $176K (Q1 2025).